| CAS NO: | 1269440-17-6 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| CAS: | 1269440-17-6 |
| 分子式: | C22H27ClFN7O4S |
| 分子量: | 540.01 |
| 纯度: | ≥98% |
| 溶解性: | DMSO |
| 存储: | Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month |
| 研究领域: | Cancer |
| Target: | IC50: 0.3 nM (BRafV600E) |
| 描述: | LGX818 is an orally available mutated BRafV600E inhibitor (IC50=0.3 nM) with potential antineoplastic activity. |
